Diligence memo · auto-generated · as of July 2, 2026
BioTuring, Inc.
BioTuring, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
BioTuring, Inc. operates in Other Health Care, based in SAN DIEGO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
BioTuring, Inc. has raised $1.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.0M on 2017-10-16.
Most recent recorded round closed around 2017-10-16.
Valuation (modeled)modeled
Provath models BioTuring, Inc. at approximately $25M (range $863K–$198M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.57× the median modeled value of Seed Other Health Care companies in 2016–2018 (222 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 8.7 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 35% of Other Health Care peers (5377 compared).
Modeled value ranks above 53% of those peers.
Closest niche peers: Eye Academy of America Ltd., Ruddco Inc., Guest House Holdings, LLC, Cb Therapeutics Inc., Shift Sciences, LLC.
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.